Adlai Nortye

China
Hengyang, Hunan, China
+86 571 2891 8366 ★

Company profile

Adlai Nortye company profile

Adlai Nortye is a global clinical-stage biopharmaceutical company focused on innovative oncology drugs, with its R&D and global clinical operation centers in both China and the United States. With a strategic emphasis on oncology, it has built a global pipeline through collaborations and internal discoveries with more than 10 drug candidates in development.

Business identity

Contact email
[email protected]
Phone number
+86 571 2891 8366
Operating status
Active
Company type
For Profit
Employee range
00051-00100 employees
Revenue range
$10K+
Founded
2016-01-01

Headquarters

Headquarters
Hengyang, Hunan, China
Postal code
311121
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
6
Total equity funding
$433M
Last funding
Post Ipo Equity / $140M / 2026-02-03
Last equity funding
Post Ipo Equity / $140M
Investors
22
Lead investors
6
Founders
1
Articles
58
Exited on
2023-09-29

Founders and investors

Founders

Carsten Lu

Lead investors

Columbia Threadneedle InvestmentsCormorant Asset ManagementMatrix Partners ChinaSDIC Fund ManagementTigermedYingke Capital

Investors

Balyasny Asset ManagementCasdin CapitalCormorant Asset ManagementMatrix Partners ChinaPoint72

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.